Abstract
The diagnosis of diseases based on immunosensors have been objective of research in the last years, providing an improvement for a rapid detection, high sensitivity, precision, accuracy, specificity and resolution. Areas of progress such as analytical technologies, interpretation and standardization has been done for common biomarkers. However, years of research and development of a functional immunosensor with an unusual biomarker require further investigation to be optimized in any aspect. Recent development of biosensors to diagnose nervous system diseases, such as immunosensors for multiple sclerosis, has been the object of study in the past 10 years to improve common in vitro diagnostic methods such as enzyme-linked immunosorbent assays (ELISA) on cerebrospinal fluid (CSF), showing a big opportunity for further diagnostic optimization. The aim of this review is to show a report on the development of in vitro immunosensors for multiple sclerosis diagnosis until today, with the particular focus on monitoring analyte concentration levels on cerebrospinal fluid and serum as a contribution and improvement to current diagnostic methods.
Similar content being viewed by others
References
Ottervald, J., Franzén, B., Nilsson, K., Andersson, L.I., Khademi, M., Eriksson, B., Kjellström, S., Marko-Varga, G., Végvári, Á., Harris, R., Laurell, T., Miliotis, T., Matusevicius, D., Saltere, H., Ferm, M., Olsson, T.: Multiple sclerosis: identification and clinical evaluation of novel CSF biomarkers. J. Prot. 73, 1117–1132 (2010)
Taveggia, C., Feltri, M.L., Wrabetz, L.: Signals to promote myelin formation and repair. Nat. Rev. Neurol. 6, 276–287 (2010)
Siegel, G.J., Albers, R.W.: Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th edn. American Society for Neurochemistry, Philadelphia, PA (1999)
French-Constant, C., Colognato, H., Franklin, R.J.M.: The mysteries of myelin unwrapped. Science 304, 688–689 (2004)
Morell, P.: Myelin, 1st edn. Springer, Boston, MA (1984)
Schaeffer, J., Cossetti, C., Mallucci, G., Pluchino, S.: Multiple sclerosis. Neurobiol. Brain Disord. Biol. Basis Neurol. Psychiatr. Disord. 1, 497–520 (2015)
Ojha, S., Kumar, B.: A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis. J. Cell. Immunother. 4, 56–64 (2018)
Goldenberg, M.M.: Multiple sclerosis review. Pharm. Ther. 37, 175 (2012)
Correale, J., Gaitán, M.I., Ysrraelit, M.C., Fiol, M.P.: Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140, 527–546 (2017)
Lassmann, H.: Pathology and disease mechanisms in different stages of multiple sclerosis. J. Neurol. Sci. 333, 1–4 (2013)
Saccà, V., Sarica, A., Novellino, F., Barone, S., Tallarico, T., Filippelli, E., Granata, A., Chiriaco, C., Bruno, R., Valentino, P., Quattrone, A.: Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis form resting-state FMRI connectivity data. Brain Imaging Behav. 13, 1103–1114 (2019)
Zhang, H., Alberts, E., Pongratz, V., Mühlau, M., Zimmer, C., Wiestler, B., Eichinger, P.: Predicting conversion from clinically isolated syndrome to multiple sclerosis—an imaging-based machine learning approach. Neuroimage Clin. 21, 101593 (2019)
Zhao, Y., Healy, B.C., Rotstein, D., Guttmann, C.R., Bakshi, R., Weiner, H.L., Brodley, C., Chitnis, T.: Exploration of machine learning techniques in predicting multiple sclerosis disease course. PLoS ONE 12, 0174866 (2017)
Ulrich, R., Kalkuhl, A., Deschl, U., Baumgärtner, W.: Machine learning approach identifies new pathways associated with demyelination in viral model of multiple sclerosis. J. Cell. Mol. Med. 14, 434–448 (2010)
Lötsch, J., Schiffmann, S., Schmitz, K., Brunkhorst, R., Lerch, F., Ferreiros, N., Wicker, S., Tegeder, I., Geisslinger, G., Ultsch, A.: Machine learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy. Sci. Rep. 8, 1–16 (2018)
Franklin, R.J.M., French-Constant, C.: Regenerating CNS myelin—from mechanisms to experimental medicines. Nat. Rev. Neurosci. 18, 753–769 (2017)
Etemadifar, M., Roomizadeh, P., Abtahi, S.H., Sajjadi, S., Abedini, A., Golabbakhsh, A., Fereidan-Esfahani, M., Akbari, M.: Linkage of multiple sclerosis and Guillain-Barre Syndrome: a population-based survey in Isfahan, Iran. Autoimmune Dis. 2012, 6 (2012)
Love, S.: Demyelinating diseases. J. Clin. Pathol. 59, 1151–1159 (2006)
Thompson, A.J., Uitdehaag, B., Taylor, B., Holloway, E., Tremlett, H., Pandit, L., Battaglia, M.: ATLAS of MS 2013, 1st edn. Summer Editorial & Design, London (2013)
Wallin, M., Culpepper, W., Nichols, E., Bhutta, Z., Gebrehiwot, T., Hay, S., Khalil, I., Krohn, K., Liang, X., Naghavi, M., Mokdad, A., Nixon, M., Reiner, R., Sartorius, B., Smith, M., Topot-Madry, R., Werdecker, A., Vos, T., Feigin, V., Murray, C.: Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 269–285 (2019)
Filippi, M., Rocca, M.A., De Stefano, N., Enzinger, C., Fisher, E., Horsfield, M.A., Inglese, M., Pelletier, D., Comi, G.: Magnetic resonance techniques in multiple sclerosis. Arch. Neurol. 68, 1514–1520 (2011)
Luque, F.A., Jaffe, S.L.: Cerebrospinal fluid analysis in multiple sclerosis. Int. Rev. Neurobiol. 79, 341–356 (2007)
McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., MacFarland, H., Paty, D., Polman, C., Reingold, S., Sandbereg, M., Sibley, W., Thompson, A.J., Van Den Noort, S., Weinshenker, B., Wolinsky, J.S.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121–127 (2001)
Polman, C.H., Reingold, S., Edan, G., Filippi, M., Hartung, H.P., Kappos, L., Lublin, F., Metz, L., McFarland, H., O’Connor, P., Sandberg, M., Thompson, A.J., Weinshenker, B., Wolinsky, J.S.: Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald criteria. Ann. Neurol. 58, 840–846 (2005)
Polman, C.H., Reingold, S., Banwell, B., Clanet, M., Cohen, J., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F., Montalban, X., O’Connor, P., Sandberg, M., Thompson, A., Waubant, E., Weinshenker, B., Wolinsky, J.: Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann. Neurol. 69, 292–302 (2011)
Deber, C.M., Reynolds, S.J.: Central nervous system myelin: structure, function, and pathology. Clin. Biochem. 24, 113–134 (1991)
Yousef, A., Jonzzon, S., Suleiman, L., Arjona, J., Graves, J.S.: Biosensing in multiple sclerosis. Expert Rev. Med. Devices. 14, 901–912 (2017)
Charcot, J.M.: Lectures on the diseases of the nervous system. New Sydenham Soc. 3, 399 (1889)
Ebringer, A.: Multiple Sclerosis, Mad Cow Disease and Acinetobacter, 1st edn. Springer, London (2015)
Rolak, L.A.: MS: the basic facts. J Clin. Med. Res. 1, 61–62 (2003)
Golgi, C.: The Neuron Doctrine—Theory And Facts, Nobel Lectures: Physiology or Medicine 1921, 1st edn. Elsevier Pub. Co., New York (1906)
Ramón y Cajal, S.: The Structure and Connexions of Neurons, Nobel Lectures: Physiology or Medicine 1901–1921, 1st edn. Elsevier Pub. Co., New York, NY (1906)
Dawson, J.W.: The histology of disseminated sclerosis. Edinb. Med. J. 17, 311 (1916)
Schwentker, F.F., Rivers, T.M.: The antibody response of rabbits to injections of emulsions and extracts of homologous brain. J. Exp. Med. 60, 559–574 (1934)
Lane, B., Carroll, B.A., Pedley, T.A.: Computerized cranial tomography in cerebral diseases of white matter. Neurology. 28, 534–534 (1978)
Young, I.R., Hall, A.S., Pallis, C.A., Bydder, G.M., Legg, N.J., Steiner, R.E.: Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 318, 1063–1066 (1981)
Strimbu, K., Tavel, J.A.: What are biomarkers? Curr. Opin. HIV AIDS. 5, 463–466 (2010)
Bielekova, B., Martin, R.: Development of biomarkers in multiple sclerosis. Brain 127, 1463–1478 (2004)
Teunissen, C.E., Malekzadeh, A., Leurs, C., Bridel, C., Killestein, J.: Body fluid biomarkers for multiple sclerosis—the long road to clinical application. Nat. Rev. Neurol. 11, 585–596 (2015)
Comabella, M., Montalban, X.: Body fluid biomarkers in multiple sclerosis. Lancet Neurol. 13, 113–126 (2014)
Harris, V.K., Sadiq, S.A.: Disease biomarkers in multiple sclerosis. Mol. Diagn. Ther. 13, 225–244 (2009)
Wei, Y., Chang, H., Li, X., Wang, H., Du, L., Zhou, H., Xu, W., Ma, Y., Yin, L., Zhang, X.: Cytokines and tissue damage biomarkers in first onset neuromyelitis optica spectrum disorders: significance of interleukin-6. NeuroImmunoModulation 25, 215–224 (2018)
Sasayama, T., Nakamizo, S., Nishihara, M., Kawamura, A., Tanaka, H., Mizukawa, K., Miyake, S., Taniguchi, M., Hosoda, K., Kohmura, E.: Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous System lymphoma (PCNSL). Nuero-oncology. 14, 368–380 (2012)
Balashov, K.E., Smith, D.R., Khoury, S.J., Hafler, D.A., Weiner, H.L.: Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. 94, 599–603 (1997)
Jha, S., Srivastava, S.Y., Brickey, W.J., Iocca, H., Toews, A., Morrison, J.P., Chen, V., Gris, D., Matsushima, G., Ting, J.P.Y.: The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J. Neurosci. 30, 15811–15820 (2010)
Selmaj, K., Raine, C.S., Cannella, B., Brosnan, C.F.: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949–954 (1991)
Lee, P., Severin, M., Lovett-Racke, A.: TGF-β regulation of T cells in multiple sclerosis. Eur. J. Immunol. 47, 446–453 (2017)
Fainardi, E., Castellazi, M., Bellini, T., Manfrinato, M.C., Baldi, E., Casetta, I., Paolino, E., Granieri, E., Dallocchio, F.: Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult. Scler. J. 12, 294–301 (2006)
Gandhi, R., Healy, B., Gholipour, T., Egorova, S., Musallam, A., Shuja, M., Nejad, P., Patel, B., Hei, H., Khoury, S., Quintana, F., Kivisakk, P., Chitnis, T., Weiner, H.: Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol. 73, 729–740 (2013)
Tumani, H., Hartung, H., Hemmer, B., Teunissen, C., Deisenhammer, F., Giovannoni, G., Zettl, U., BioMS Study Group. The BioMS Study Group: Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol. Dis. 35, 117–127 (2009)
Bhalla, N., Jolly, P., Formisano, N., Estrela, P.: Introduction to biosensors. Essays Biochem. 60, 1–8 (2016)
Mollarasouli, F., Kurbanoglu, S., Ozkan, S.: The role of electrochemical immunosensors in clinical analysis. Biosensors. 9, 86 (2019)
La Belle, J.T., Bhavsar, K., Fairchild, A., Das, A., Sweeney, J., Alford, T.L., Wang, J., Bhavanandan, V., Joshi, L.: A cytokine immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy. Biosens. Bioelectron. 23, 428–431 (2007)
Kang, X., Wang, J., Wu, H., Aksay, I.A., Liu, J., Lin, Y.: Glucose oxidase–graphene–chitosan modified electrode for direct electrochemistry and glucose sensing. Biosens. Bioelectron. 25, 901–905 (2009)
Asif, M.H., Ali, S.M.U., Nur, O., Willander, M., Brännmark, C., Stralfors, P., Englund, U., Elinder, F., Danielsson, B.: Functionalised ZnO-nanorod-based selective electrochemical sensor for intracellular glucose. Biosens. Bioelectron. 25, 2205–2211 (2010)
Heller, A., Feldman, B.: Electrochemical glucose sensors and their applications in diabetes management. Chem. Rev. 108, 2482–2505 (2008)
Ricci, F., Adornetto, G., Palleschi, G.: A review of experimental aspects of electrochemical immunosensors. Electrochim. Acta. 84, 74–83 (2012)
Leonard, J.P., Waldburger, K.E., Goldman, S.J.: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181, 381–386 (1995)
Tsekenis, G., Garifallou, G.Z., Davis, F., Millner, P.A., Gibson, T.D., Higson, S.P.: Label-less immunosensor assay for myelin basic protein based upon an ac impedance protocol. Anal. Chem. 80, 2058–2062 (2008)
Orth, R.N., Clark, T.G., Craighead, H.G.: Avidin-biotin micropatterning methods for biosensor applications. Biomed. Microdevices. 5, 29–34 (2003)
Hsu, S.M., Raine, L., Fanger, H.: The use of avidin-biotin-peroxidase (ABC) complex in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577–580 (1981)
Real-Fernández, F., Colson, A., Bayardon, J., Nuti, F., Peroni, E., Meunier-Prest, R., Lolli, F., Chelli, M., Darcel, C., Jugé, S., Papini, A.M.: Ferrocenyl glycopeptides as electrochemical probes to detect autoantibodies in multiple sclerosis patients’ Sera. J. Pept. Sci. 90, 488–495 (2008)
Bhavsar, K., Fairchild, A., Alonas, E., Bishop, D., La Belle, J.T., Sweeney, J., Alford, T.L., Joshi, L.: A cytokine immunosensor for Multiple Sclerosis detection based upon label-free electrochemical impedance spectroscopy using electroplated printed circuit board electrodes. Biosens. Bioelectron. 25, 506–509 (2009)
Nguyen, H.H., Park, J., Kang, S., Kim, M.: Surface plasmon resonance: a versatile technique for biosensor applications. Sensors. 15, 10481–10510 (2015)
Real-Fernández, F., Passalacqua, I., Peroni, E., Chelli, M., Lolli, F., Papini, A.M., Rovero, P.: Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance. Sensors. 12, 5596–5607 (2012)
Derkus, B., Emregul, E., Yucesan, C., Emregul, K.C.: Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy. Biosens. Bioelectron. 46, 53–60 (2013)
Sungur, S.U.B., Emregul, E., Günendi, G., Numanoglu, Y.U.N.: New glucose biosensor based on glucose oxidase-immobilized gelatin film coated electrodes. J. Biomater. Appl. 18, 265–277 (2004)
Periasamy, A.P., Chang, Y.J., Chen, S.M.: Amperometric glucose sensor based on glucose oxidase immobilized on gelatin-multiwalled carbon nanotube modified glassy carbon electrode. Bioelectrochemistry 80, 114–120 (2011)
Mohamed, H.H., Dillert, R., Bahnemann, D.W.: TiO2 nanoparticles as electron pools: Single- and multi-step electron transfer processes. J. Photochem. Photobiol. A. 245, 9–17 (2012)
Derkus, B., Emregul, E., Emregul, K.C., Yucesan, C.: Alginate and alginate-titanium dioxide nanocomposite as electrode materials for anti-myelin basic protein immunosensing. Sens. Actuators B-Chem. 192, 294–302 (2014)
Lee, K.Y., Mooney, D.J.: Alginate: properties and biomedical applications. Prog. Polym. Sci. 37, 106–126 (2012)
Zhao, H.Y., Zheng, W., Meng, Z.X., Zhou, H.M., Xu, X.X., Li, Z., Zheng, Y.F.: Bioelectrochemistry of hemoglobin immobilized on a sodium alginate-multiwall carbon nanotubes composite film. Biosens. Bioelectron. 24, 2352–2357 (2009)
Ionescu, R.E., Abu-Rabeah, K., Cosnier, S., Marks, R.S.: Improved enzyme retention from an electropolymerized polypyrrole-alginate matrix in the development of biosensors. Electrochem. Commun. 7, 1277–1282 (2005)
Pan, B., Fromholt, S.E., Hess, E.J., Crawford, T.O., Griffin, J.W., Sheikh, K.A., Schnaar, R.L.: Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single-and double-null mice. Exp. Neurol. 195, 208–217 (2005)
Biela, A., Watkinson, M., Meier, U.C., Baker, D., Giovannoni, G., Becer, C.R., Krause, S.: Disposable MMP-9 sensor based on the degradation of peptide cross-linked hydrogel films using electrochemical impedance spectroscopy. Biosens. Bioelectron. 68, 660–667 (2015)
Venugopal, I., Sirhan, R., Basati, S., Linninger, A.A.: Prototype biosensor for detection of myelin basic protein biomarker in hydrocephalus diagnosis. Sens. Lett. 14, 84–92 (2016)
Derkus, B., Bozkurt, P.A., Tulu, M., Emregul, K.C., Yucesan, C., Emregul, E.: Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of multiple sclerosis patients using nanoimmunosensor. Biosens. Bioelectron. 89, 781–788 (2017)
Mansourian, N., Rahaie, M., Hosseini, M.: A Nanobiosensor based on fluorerescent DNA-hosted silver nanocluster and HCR amplification for detection of microRNA involved in progression of multiple sclerosis. J. Fluoresc. 27, 1679–1685 (2017)
Song, J., Dailey, D., Li, H., Jang, H., Russell, L., Zhang, P., Searson, P., Wang, J., Everett, A., Katz, H.: Influence of bioreceptor layer structure on myelin basic protein detection using organic field effect transistor-based biosensors. Adv. Funct. Mater. 28, 1802605 (2018)
Soto, P., Guimaraes, D., Oliveira, O., Martins, A., Magalhaes, J., De Souza, A., Makoto, F., Okuda, N., Pereoni, L., Diniz, P., Machini, M., Lima, F.: Nanoimmunosensor based on atomic force spectroscopy to detect anti-myelin basic protein related to early-stage multiple sclerosis. Ultramicroscopy 211, 112946 (2020)
Wang, Y.W., Chen, T.Y., Yang, T.H., Chang, C.C., Yang, T.L., Lo, Y.H., Huang, J.J.: Thin-film transistor-based biosensors for determining stoichiometry of biochemical reactions. PLoS ONE 11, 2–9 (2016)
Shen, Y.C., Yang, C.H., Chen, S.W., Wu, S.H., Yang, T.L., Huang, J.J.: IGZO thin film transistor biosensors functionalized with ZnO nanorods and antibodies. Biosens. Bioelectron. 54, 306–310 (2014)
Acknowledgements
This work was supported by CONACYT, México (Grant number 294690)
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests.
Rights and permissions
About this article
Cite this article
Guerrero, J.M., Aguirre, F.S., Mota, M.L. et al. Advances for the Development of In Vitro Immunosensors for Multiple Sclerosis Diagnosis. BioChip J 15, 205–215 (2021). https://doi.org/10.1007/s13206-021-00018-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-021-00018-z